PRESS INQUIRIES

Press Releases

Mapp Bio in the News

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

January 13, 2021

MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical Countermeasure

June 11, 2019

Experimental antibody ‘cocktail’ protects animals from three deadly Ebola viruses

January 11, 2019

Clinical Trial of Investigational Ebola Treatments Begin In Democratic Republic Of Congo

November 27, 2018

Mapp Bio Press Release
Antibody-based Contraceptive Research Center Awarded to Boston University Led Consortium

October 17, 2018

MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure

September 28, 2018

Mapp Bio Press Release
MappBio Announces Contracts with BARDA for ZMappTM and Additional Filovirus Medical Countermeasures

September 29, 2017

Researchers Discover First Human Antibodies That Work Against All Ebolaviruses

May 19, 2017

Researchers develop Marburg virus treatment effective five days after infection

April 5, 2017

Mapp Bio
LeafBio Announces NEJM Publication of ZMapp™ Clinical Trial

October 13, 2016

Mapp Bio Receives HHS Funding for Expanded Access Protocol for Ebola Treatment
Mapp Bio Receives HHS Funding for Expanded Access Protocol for Ebola Treatment

August 8, 2016

Mapp Bio
LeafBio Announces Conclusion of ZMapp™ Clinical Trial

February 23, 2016

© 2017 Mapp Biopharmaceautical - Leaf Bio. All Rights Reserved.